Literature DB >> 11409418

When running a stop sign may be a good thing.

G Karpati, H Lochmuller.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11409418

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  Aminoglycoside treatment for muscular dystrophy is scientifically rational, but is it clinically effective?

Authors:  Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

2.  Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.

Authors:  Jeyakumar Kandasamy; Dana Atia-Glikin; Eli Shulman; Katya Shapira; Michal Shavit; Valery Belakhov; Timor Baasov
Journal:  J Med Chem       Date:  2012-11-29       Impact factor: 7.446

Review 3.  Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).

Authors:  Richard S Finkel
Journal:  J Child Neurol       Date:  2010-06-02       Impact factor: 1.987

4.  Read-through approach for stop mutations in Duchenne muscular dystrophy. An update.

Authors:  Luisa Politano
Journal:  Acta Myol       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.